Correlation Between Morgan Stanley and Biogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Biogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Biogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley and Biogen Inc, you can compare the effects of market volatilities on Morgan Stanley and Biogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Biogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Biogen.

Diversification Opportunities for Morgan Stanley and Biogen

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Morgan and Biogen is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley and Biogen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biogen Inc and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley are associated (or correlated) with Biogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biogen Inc has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Biogen go up and down completely randomly.

Pair Corralation between Morgan Stanley and Biogen

Assuming the 90 days horizon Morgan Stanley is expected to generate 1.11 times more return on investment than Biogen. However, Morgan Stanley is 1.11 times more volatile than Biogen Inc. It trades about 0.06 of its potential returns per unit of risk. Biogen Inc is currently generating about -0.06 per unit of risk. If you would invest  153,293  in Morgan Stanley on September 24, 2024 and sell it today you would earn a total of  94,691  from holding Morgan Stanley or generate 61.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Morgan Stanley  vs.  Biogen Inc

 Performance 
       Timeline  
Morgan Stanley 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Morgan Stanley showed solid returns over the last few months and may actually be approaching a breakup point.
Biogen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Morgan Stanley and Biogen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Biogen

The main advantage of trading using opposite Morgan Stanley and Biogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Biogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will offset losses from the drop in Biogen's long position.
The idea behind Morgan Stanley and Biogen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance